CAR-T Meeting 2024 | Factors to consider when managing patients with ALL prior to CAR T-cell therapy
Pere Barba
• 15 Feb 2024
In this video, Pere Barba, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, briefly outlines the factors that clinicians should consider when managing patients with acute lymphoblastic leukemia (ALL) prior to CAR-T therapy. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Allogene, Amgen, BMS/Celgene, Kite/Gilead, Incyte, Novartis, Pierre Fabre
